Multiple meningiomas

Clinical Nuclear Medicine

Volumn 30, Issue 5, 2005, Pages 361-362

  Leondi, A ^a,b   Valotassiou, V ^a   Koutsikos, J ^a   Tsiouris, S ^a   Mainta, E ^a   Zerva, C ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

In 111 pentetreotide; Meningiomas; Somatostatin receptor scintigraphy

Indexed keywords

PENTETREOTIDE IN 111;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG UPTAKE; EYE DISEASE; FEMALE; HUMAN; HYPERTHYROIDISM; MENINGIOMA; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; RIGHT HEMISPHERE; SCINTIGRAPHY; SYMPTOM; THYROID GLAND;

BRAIN NEOPLASMS; FEMALE; GRAVES DISEASE; HUMANS; INCIDENTAL FINDINGS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RADIOPHARMACEUTICALS; SOMATOSTATIN;

EID: 17644425644     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000159910.88512.65     Document Type: Article

References (12)

1. Durak I, Durak H, Ergin M, et al. Somatostatin receptors in the orbits. Clin Nucl Med. 1995;20:237-242.
2. Durak H, Soylev M, Durak I, et al. Tc-99m polyclonal human immunoglobulin G imaging in Graves' ophthalmopathy. Clin Nucl Med. 2000;25:704-707.
3. Konuk O, Atasever T, Unal M, et al. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy. Thyroid. 2002;12:603-608.
4. Moncayo R, Baldissera I, Decristoforo C, et al. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111ln-octreotide. Thyroid. 1997;7:21-29.
5. Pichler R, Maschek W, Holzinger C. Therapy with somatostatin analogs in patient with orbitopathy and positive OctreoScan. Acta Med Aust. 2001;28:99-101.
6. Lamberts SW, Koper JW, Reubi JC, et al. Endocrine aspects of the diagnosis and treatment of primary brain tumours. Clin Endocrinol (Oxf). 1992;37:1-10.
7. Schulz S, Pauli SU, Schulz S, et al. Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A. Clin Cancer Res. 2000;6:1865-1874.
8. Cavalla P, Schiffer D. Neuroendocrine tumors in the brain. Ann Oncol. 2001;12(suppl 2):S131-134.
9. Luyken C, Hildebrandt G, Krisch B, et al. Clinical relevance of somatostatin receptor scintigraphy in patients with skull base tumours. Acta Neurochir Suppl (Wien). 1996;65:102-104.
10. Roland J, Pickut BA, Abib A, et al. Primary cerebral lymphoma visualised by means of In-111-pentetreotide scintigraphy. Acta Neurol Belg. 1998;98:356-359.
11. Maini CL, Sciuto R, Tofani A, et al. Somatostatin receptor imaging in CNS tumours using 111ln-octreotide. Nucl Med Commun. 1995;16(9):756-766.
12. Li X, Jin H, Lu Y, et al. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed. 2004;17:10-20.